AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Policy Tracker · Official source

United Kingdom

Where this status comes from, in the government's own words.

Current status

Prohibited

Illegal to possess, use or sell.

Not yet checked against the official law — treat as provisional.

Official law

Misuse of Drugs Act 1971, Schedule 2

Published by legislation.gov.uk

Schedule 2, Part I — Class A drugs (paragraph 1, excerpts)
Fungus (of any kind) which contains psilocin or an ester of psilocin. Lysergamide. Lysergide and other N-alkyl derivatives of lysergamide. Mescaline. N,N-Dimethyltryptamine. Psilocin.
Schedule 2, Part I — paragraph 3
Any stereoisomeric form of a substance for the time being specified in paragraph 1 or 2 above.

Show on the map Country overview All legal sources

Loading source…